9 Commonly Asked Questions About Spinraza

Spinraza (Nusinersen) was approved by the FDA in December 2016 for the treatment of children and adults with spinal muscular atrophy (SMA). It’s had the SMA community buzzing the world over, but as the drug becomes available in more countries, there are some common questions that keep coming up.

According to Cure SMA here are some of the most frequently asked questions about Spinraza:

When will Spinraza be available?
Spinraza is available in the U.S. and many countries worldwide. You’ll need to check with your doctor to see if it’s available in your area.

Will my insurance cover the treatment?
This will depend on individual insurance policies. However, the manufacturer of the drug, Biogen, has a support system in place to help assist with insurance matters regarding Spinraza.

MORE: Child with SMA dismissed as a “lazy baby” now thriving on Spinraza.

Leave a Comment

Your email address will not be published. Required fields are marked *